CEBIOTEX has closed in December, 2016 a financing round of 1,800,000 Euros to continue the regulatory phase of his product with a pediatric focus, task in which it is currently focused.



CEBFUNDING has made an investment of 600,000 Euros from investors through Crowdfunding platform CapitalCell. These funds have been invested in CEBIOTEX as part of the financing round closed in December, 2016